Seer, Inc. (California) (SEER)
1.89
-0.02
(-1.05%)
USD |
NASDAQ |
Jan 16, 16:00
1.87
-0.02
(-1.06%)
Pre-Market: 09:23
Seer EPS Diluted (Quarterly): -0.3238 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.567 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.23M |
| Revenue (Quarterly) | 4.121M |
| Total Expenses (Quarterly) | 22.36M |
| Enterprise Value | -68.67M |
| Gross Profit Margin (Quarterly) | 51.20% |
| Profit Margin (Quarterly) | -442.5% |
| Earnings Yield | -72.06% |
| Normalized Earnings Yield | -72.06 |